Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac)_ interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Auteur/autrice de la publication :Admin Post published:27 septembre 2021 Post category:COVID 19 Post comments:0 commentaire Efficacy-and-safety-of-an-inactivated-whole-virion-SARS-CoV-2-vaccine-CoronaVac_-interim-results-of-a-double-blind-randomised-placebo-controlled-phase-3-trial-in-Turkey-2Télécharger Vous devriez également aimer Genomic-informed pathogen surveillance in Africa_ opportunities and challenges 15 février 2021 Interprétation des tests COVID19 CHU Babeloued 14 décembre 2020 Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome 7 mars 2021 Laisser un commentaire Annuler la réponseCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Enregistrer mon nom, mon e-mail et mon site dans le navigateur pour mon prochain commentaire.
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome 7 mars 2021
